Jacobio Pharmaceuticals Group Co., Ltd.
HKEX:1167.HK
10.52 (HKD) • At close September 3, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2024 Q4 | 2024 Q2 | 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 Q2 | 2021 Q4 | 2021 Q2 | 2020 Q4 | 2020 Q2 | 2019 Q4 | 2019 Q2 | 2018 Q4 | 2018 Q2 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||||||
| Net Income
| 13.344 | -169.053 | -192.838 | -166.281 | -244.036 | -127.825 | -164.59 | -136.597 | -702.759 | -810.896 | -270.694 | -154.117 | -77.968 | -77.968 |
| Depreciation & Amortization
| 0 | 13.75 | 15.124 | 9.956 | 7.387 | 6.408 | 5.906 | 4.885 | 3.408 | 4.873 | 5.002 | 8.185 | 4.256 | 4.256 |
| Deferred Income Tax
| 0 | 0 | 0 | 0 | -43.66 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 24.615 | 24.615 |
| Stock Based Compensation
| 4.555 | 5.409 | 7.559 | 7.298 | 10.505 | 6.488 | 8.62 | 10.829 | 12.85 | 6.806 | 68.29 | 0.354 | 5.86 | 5.86 |
| Change In Working Capital
| 0 | 0 | 2.622 | 0 | 86.828 | 0 | 88.871 | 0 | -174.838 | 0 | 2.459 | -1.379 | 2.492 | 2.492 |
| Accounts Receivables
| 0 | 0 | 10.378 | 0 | 79.074 | 0 | 89.031 | 0 | -187.936 | 0 | -1.177 | -0.543 | -3.299 | -3.299 |
| Change In Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Accounts Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital
| 0 | 0 | -7.756 | 0 | 7.754 | 0 | -0.16 | 0 | 13.098 | 0 | 3.636 | -0.836 | 0.741 | 0.741 |
| Other Non Cash Items
| -17.899 | -30.531 | 23.095 | -70.734 | -41.276 | 3.103 | 28.453 | 6.131 | 1,012.167 | 727.214 | 128.049 | 100.826 | 0.799 | 0.799 |
| Operating Cash Flow
| 0 | -180.425 | -144.438 | -219.761 | -180.592 | -111.826 | -32.74 | -114.752 | 150.828 | -72.003 | -66.894 | -46.131 | -39.947 | -39.947 |
| Investing Activities: | ||||||||||||||
| Investments In Property Plant And Equipment
| 0 | -5.479 | -3.453 | -34.376 | -13.638 | -2.806 | -2.725 | -7.381 | -9.39 | -0.748 | -1.614 | -1.728 | -8.04 | -8.04 |
| Acquisitions Net
| 0 | 0 | 0 | 3.257 | 0.097 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.692 | 0.692 |
| Purchases Of Investments
| 0 | 0 | 0 | -658.273 | -1,485.828 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -75.305 | -75.305 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 1,091.281 | -0.941 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 102.425 | 102.425 |
| Other Investing Activites
| 0 | 49.176 | -215.152 | 204.98 | -670.981 | 1.103 | -17.72 | 189.493 | -136.048 | -69.378 | 215.874 | -212.805 | -12.48 | -12.48 |
| Investing Cash Flow
| 0 | 43.697 | -218.605 | 170.604 | -684.619 | -1.703 | -20.445 | 182.112 | -145.438 | -70.126 | 214.26 | -214.533 | 7.292 | 7.292 |
| Financing Activities: | ||||||||||||||
| Debt Repayment
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 0 | 0 | 0 | 314.715 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | -3.29 | -5.682 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -8.525 | -8.525 |
| Other Financing Activities
| 0 | 29.05 | 62.63 | 189.33 | -6.832 | -3.022 | -10.585 | 119.642 | 1,112.639 | 162.742 | -10.743 | 11.672 | 186.938 | 186.938 |
| Financing Cash Flow
| 0 | 25.76 | 56.948 | 189.33 | -6.832 | -3.022 | -10.585 | 119.642 | 1,112.639 | 162.742 | -10.743 | 11.672 | 178.414 | 178.414 |
| Other Information: | ||||||||||||||
| Effect Of Forex Changes On Cash
| 0 | 3.621 | -8.372 | 19.074 | 36.528 | 49.237 | -14.177 | -12.267 | -23.613 | 1.049 | 10.378 | -4.504 | 1.225 | 1.225 |
| Net Change In Cash
| -361.808 | 361.808 | -157.234 | -57.88 | -261.007 | -33.657 | -38.974 | 87.368 | 547.208 | 10.831 | 73.501 | -126.748 | 293.968 | 293.968 |
| Cash At End Of Period
| 0 | -53.674 | -157.234 | 1,400.209 | 1,458.089 | 1,459.89 | -38.974 | 1,605.151 | 547.208 | 336 | 73.501 | 167.337 | 420.833 | 420.833 |